Evidence map›Paper›PMID 32443684›Full record

Trial reportNutrients2020

Early Effect of Supplemented Infant Formulae on Intestinal Biomarkers and Microbiota: A Randomized Clinical Trial.

Mireille Castanet, Christos Costalos, Nadja Haiden, Jean-Michel Hascoet, Bernard Berger, Norbert Sprenger, Dominik Grathwohl, Harald Brüssow, Nanda De Groot, Philippe Steenhout and 3 more

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05524649 (Safety, Tolerability and Effect on Fecal Microbiota Composition of Two Probiotic Strains in Infants), which is not on this map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05524649 narecruitingnot on this mapstarted 2022, after this paper: background citation

Safety, Tolerability and Effect on Fecal Microbiota Composition of Two Probiotic Strains in Infants

TypeinterventionalSponsorAB Biotics, SARan2022 to 2025Enrolled120ConditionsMicrobial ColonizationArmsFood Supplement 1, Food Supplement 2, Placebo
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Safety and Tolerance ofNutrients · 2025
    Trial
  3. Effect ofNutrients · 2023
    Trial
  4. Trial
  5. Review
  6. Article
  7. Human milkFrontiers in nutrition · 2025
    Review
  8. Review
  9. Observational
  10. Article
  11. Review
  12. Article
  13. Observational
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 4 countries.

Mireille CastanetCIC INSERM U1404, Department of Pediatric, Rouen University Hospital Charles Nicolle, 76031 Rouen, France.
Christos CostalosDepartment of Neonatology, Alexandra Regional General Hospital, 11528 Athens, Greece.
Nadja HaidenDepartment of Clinical Pharmacology, Medical University of Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria.ORCID 0000-0003-4806-0312
Jean-Michel HascoetDepartment of Neonatology, Maternite Regionale, CHRU Nancy, 54035 Nancy, France.
Bernard BergerNestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland.
Norbert SprengerNestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland.
Dominik GrathwohlNestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland.
Harald BrüssowNestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland.
Nanda De GrootSBU Nutrition, Nestlé, 1800 Vevey, Switzerland.
Philippe SteenhoutNestlé Health Science, 1066 Epalinges, Switzerland.
Sophie PecquetSBU Nutrition, Nestlé, 1800 Vevey, Switzerland.ORCID 0000-0003-4669-467X
Jalil BenyacoubNestlé Research, Société des Produits Nestlé S.A., 1000 Lausanne, Switzerland.
Jean-Charles PicaudDepartment of Neonatology, University Hospital Croix Rousse, Hospices Civils de Lyon, 69317 Lyon France.ORCID 0000-0002-4999-6668
Nestlé (Switzerland) · CHAlexandra Hospital · GRDéveloppement, Adaptation et HandicapInserm · FRMedical University of Vienna · ATUniversité Claude Bernard Lyon 1 · FR

Funding

Société des produits Nestlé S.A. N/A
6 · The paper itself

Abstract

backgroundPost-natal gut maturation in infants interrelates maturation of the morphology, digestive, and immunological functions and gut microbiota development. Here, we explored both microbiota development and markers of gut barrier and maturation in healthy term infants during their early life to assess the interconnection of gut functions during different infant formulae regimes.

methodsA total of 203 infants were enrolled in this randomized double-blind controlled trial including a breastfed reference group. Infants were fed starter formulae for the first four weeks of life, supplemented with different combination of nutrients (lactoferrin, probiotics (

resultsInfants fed formula containing BMOS had lower mean calprotectin levels over the first two to four weeks compared to the other formula groups. Elastase and AAT levels were closer to levels observed in breastfed infants. No differences were observed for neopterin. Global differences between the bacterial communities of all groups were assessed by constrained multivariate analysis with hypothesis testing. The canonical correspondence analysis (CCA) at genus level showed overlap between microbiota profiles at one and four weeks of age in the BMOS supplemented formula group with the breastfed reference, dominated by bifidobacteria. Microbiota profiles of all groups at four weeks were significantly associated with the calprotectin levels at 4 (CCA,

conclusionA meaningful correlation was observed between changes in microbiota composition and gut maturation marker calprotectin. The supplementation with BMOS seems to favor gut maturation closer to that of breastfed infants.

Indexed as

BiomarkersDietary SupplementsAnimalsBifidobacterium animalisBreast FeedingDouble-Blind MethodFecesGastrointestinal MicrobiomeHumansInfantInfant FormulaLeukocyte L1 Antigen ComplexMilkOligosaccharidesPrebioticsProbioticsBiomarkersLeukocyte L1 Antigen ComplexOligosaccharidesPrebioticsearly gut maturationinfant microbiotaprebioticsprobiotics

Identifiers

PMID32443684
PMCPMC7284641
OpenAlexW3027286068

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.